Philadelphia Chromosome-negative Myeloproliferative Neoplasms

Top drugs studied for this disease

CLINICAL_TRIALS withdrawal · 2024-07-31
Clinical Trial Update: A Study of Fedratinib With IDH Inhibition in Advanced-Phase, IDH-Mutated Ph-Negative Myeloproliferative Neoplasms [Phase 1]
This document announces that a Phase 1 study of fedratinib with an IDH inhibitor in IDH-mutated Philadelphia chromosome-negative myeloprolif…